Comparative Analysis of Serum Proteomes for Discovery of Biomarkers for Human Lung Squamous Carcinoma

LI Cui,XIAO Zhi-qiang,ZHANG Xiao-peng,CHEN Zhu-Chu,WU Xiao-ying,FENG Xue-Ping,ZHANG Peng-Fei,LI Jian-ling,YI Hong,LIANG Song-ping

DOI: https://doi.org/10.3969/j.issn.1007-7626.2005.03.013

2005-01-01

Abstract:Carcinogenesis of lung squamous carcinoma(LSC) is a complex process involving multiple events and steps. However,the definite diagnostic and prognostic protein biomarker for LSC are still unclear. To identify tumor-associated antigens by using serologic proteome analysis (SERPA), an approach which combines conventional proteome analysis with serological screening.SERPA of ten human lung squamous carcinoma tissues were performed. Three gels were run simultaneously with equal amounts of proteins from the same lung squamous carcinoma by IPG-2D PAGE. After separation, the proteins of one replica gel was visualized by silver-based staining technique. The other two gels were used for Western blot analysis. Proteins are transferred to NC membranes, then reacted with autologous patient serum and with control normal serum, respectively. The Western blot imaging films were obtained and the differential reacting protein spots were recognized, then the differential reacting protein spots in the replica gel by matching analysis. Well-resolved, reproducible 2-DE Western blot imaging films of human lung squamous carcinoma reacted with autologous patient sera and with control sera were obtained. 36 ±8 differentially expressed proteins which only were reactive with lung squamous carcinoma patient sera were found. Fourteen proteins, which are lung squamous carcinoma-associated antigens, were identified by peptide mass fingerpriting analysis with relative software. some proteins were the products of oncogenes, and others involve in the regulation of cell cycle and signal transduction. Well-resolved, reproducible 2-DE Western blot imaging films of human lung squamous carcinoma reacted with autologous patient sera and with control sera were obtained and fourteen tumor-associated antigens were characterized by using SERPA. These results may provide scientific foundation for screening the molecular biomarker used to diagnose and treat lung squamous carcinoma, as well as to elevate the patient's prognosis and provide new clue for the research of lung squamous carcinogenic mechanism.